Raghu Rao serves as Executive at Sonnet BioTherapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Raghu Rao has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 2, 2025 involved selling 22,356 shares valued at $0.
Raghu Rao currently holds 22,356 shares of Sonnet BioTherapeutics Holdings, Inc. (SONN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raghu Rao has been a net neutral trader of SONN stock. They have purchased $0 and sold $0 worth of shares.
Raghu Rao's most recent insider trade was on Dec 2, 2025, when they sold 22,356 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 27, 2023 | SONN | $0 | Purchase | 15,625 | $N/A | Discretionary |
| Dec 14, 2022 | SONN | $0 | Award | 3,770 | $N/A | Discretionary |
| Dec 15, 2021 | SONN | $0 | Award | 14,152 | $N/A | Discretionary |
| Jul 2, 2020 | SONN | $0 | Award | 8,005 | $N/A | Discretionary |
| Apr 1, 2020 | SONN | $0 | Award | 213 | $N/A | Discretionary |